Picture of Probi AB logo

PROB — Probi AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Brief: Probi: Clinical Trial Confirms Immune Enhancing Impact Of Probi Defendum

Feb 6 (Reuters) - PROBI  PROB.ST : 
    * LARGEST CLINICAL TRIAL CONFIRMS THE IMMUNE ENHANCING 
IMPACT OF 
PROBI DEFENDUM AND SHEDS NEW LIGHT ON THE MECHANISM 
    * RESULTS FROM STUDY SHOW THAT PROBI DEFENDUM 
SIGNIFICANTLY 
DECREASES RECURRENT COMMON COLDS 
 
Source text for Eikon:  ID:nWkr5LXZ98  
Further company coverage:  PROB.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Probi AB

See all news